Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD
Authors
Keywords
Cardiovascular event, Chronic kidney disease, Kidney outcome, Low-density lipoprotein cholesterol, Mortality
Journal
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 32, Issue 2, Pages 410-419
Publisher
Elsevier BV
Online
2021-10-14
DOI
10.1016/j.numecd.2021.09.037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indoxyl Sulfate, a Uremic Endotheliotoxin
- (2020) Guillaume Lano et al. Toxins
- Longitudinal Lipid Trends and Adverse Outcomes in Patients with Chronic Kidney Disease: A 13-Year Observational Cohort Study Using Registry-Based Electronic Medical Records
- (2019) Ching-Wei Tsai et al. JOURNAL OF LIPID RESEARCH
- Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
- (2019) Archna Bajaj et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease
- (2019) Frida Emanuelsson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
- (2018) Karen A. Hicks et al. CIRCULATION
- Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease
- (2018) Julio A Lamprea-Montealegre et al. HEART
- Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study
- (2018) Richard L. Amdur et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Lipid management in patients with chronic kidney disease
- (2018) Charles J. Ferro et al. Nature Reviews Nephrology
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
- (2016) Nans Florens et al. Toxins
- Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population
- (2016) Michael Thompson et al. Journal of Clinical Medicine
- Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Effects of Lowering LDL Cholesterol on Progression of Kidney Disease
- (2014) R. Haynes et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods
- (2014) Kook-Hwan Oh et al. BMC Nephrology
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: A meta-analysis of prospective cohort studies
- (2013) Yujie Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Association between LDL-C and Risk of Myocardial Infarction in CKD
- (2013) M. Tonelli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial
- (2010) Robert G. Fassett et al. ATHEROSCLEROSIS
- Hyperlipidemia and Long-Term Outcomes in Nondiabetic Chronic Kidney Disease
- (2010) V. Chawla et al. Clinical Journal of the American Society of Nephrology
- Receiver Operating Characteristic Curve in Diagnostic Test Assessment
- (2010) Jayawant N. Mandrekar Journal of Thoracic Oncology
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of simvastatin on kidney function loss in patients with coronary heart disease
- (2008) Janna Huskey et al. ATHEROSCLEROSIS
- Survival analysis: time-dependent effects and time-varying risk factors
- (2008) Friedo W. Dekker et al. KIDNEY INTERNATIONAL
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now